CClinicalTrials.gg
Status unknownNCT04122781Updated May 13, 2020

Treatment of Pediatric Supracondylar Humeral Fractures With Novel Kirschner Wire Fixation Devices

An interventional study of Novel K-wire fixation devices in Supracondylar Humerus Fracture, sponsored by Chang Gung Memorial Hospital. Status unknown at 1 site in Taiwan. Open to participants aged Up to 20 Years. Per ClinicalTrials.gov, last updated 2020-05-13.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2019, registered Sep 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
Up to 20 Years
Sex
All
01

Study summary

A novel K-wire external fixation device was developed by the investigators. The K-wires can be connected by the device. After connection, the structure of the K-wires is transformed to an external skeletal fixator. Therefore, the K-wires are stabilized and unable to migrate independently. The stability of fracture fixation is better in patient with this K-wire external fixation device.

The purposes of this study are to optimize the K-wire external fixation device and test its function in real clinical practice.

Read the detailed description

Supracondylar humeral fractures are the most common elbow fractures in children. Closed reduction and internal fixation using percutaneous Kirschner wires (K-wires) are widely recommended for Gartland type II and III fractures. After percutaneous pinning, the K-wires are bent at the skin edge and cut. The cutoff point is about 1 cm outside of the skin.

The diameters of the K-wires are between 1.5-3.0 mm. The surface of the K-wire is smooth. Therefore, the K-wires are easy to rotation and migration. Proximal migration or rotation of a K-wire could injure the skin. Distal migration of a K-wire could result in loss of reduction and fixation. Therefore, stabilization of the K-wires is important.

A novel K-wire external fixation device was developed by the investigators. The K-wires can be connected by the device. After connection, the structure of the K-wires is transformed to an external skeletal fixator. Therefore, the K-wires are stabilized and unable to migrate independently. The stability of fracture fixation is better in patient with this K-wire external fixation device.

The investigators got a one-year grant from the Ministry of Science and Technology in Taiwan last year. The preliminary data revealed that the torque and torsional stiffness with the K-wire external fixation device was greater than traditional pinning.

The purposes of this study are to optimize the K-wire external fixation device and test its function in real clinical practice.

02

Conditions studied

  • Supracondylar Humerus Fracture

Keywords

  • supracondylar humerus fracture
  • Kirschner wire
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 30 is below the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric supracondylar humeral fracture
  • Patients receiving closed reduction and percutaneous pinning

Exclusion criteria

Exclusion Criteria:

  • Open fracture
  • Open reduction
  • Neurovascular exploration
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    with novel K-wire fixation devices

    Patients with supracondylar humeral fractures treated by percutaneous K-wire fixation and novel K-wire fixation devices

    Device: Novel K-wire fixation devices

  • Active comparator
    without novel K-wire fixation devices

    Patients with supracondylar humeral fractures treated by percutaneous K-wire fixation

    Device: Novel K-wire fixation devices

Interventions

  • DeviceNovel K-wire fixation devices

    The patients received surgery using novel K-wire fixation devices

06

What researchers measure

Primary outcomes

  1. Radiographs measurement

    Baumann angle and the location of anterior humeral line on the radiographs

    Time frame: through study completion, an average of 1 year

  2. Elbow range of motion

    Elbow flexion an extension angle

    Time frame: through study completion, an average of 1 year

  3. Pin sites condition

    The pin sites were inspected and graded according to the system of Dahl. Grade 0 was normal skin, grade 1 was pain or erythema without discharge, grade 2 was serous discharge, grade 3 was purulent discharge, grade 4 was radiographic osteolysis and grade 5 was ring sequestrum or osteomyelitis.

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04122781
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Sponsor
First posted
Oct 10, 2019
Start date
Apr 15, 2019
Primary completion
Jul 31, 2020 (estimated)
Completion
Jul 31, 2020 (estimated)
Last update
May 13, 2020

Study contacts

Hsuan-Kai Kao
Contact
samiyadondon@gmail.com
+88633281200 ext. 2423
Hsuan-Kai Kao
principal investigator · Chang Gung Memorial Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion